Multiple Sclerosis and Cannabinoid-based Medicines
No two cases of Multiple Sclerosis (MS) look the same – the trajectories, outcomes, symptoms and experiences of those living with MS vary from person…
Multiple Sclerosis
Multiple Sclerosis and Nabiximols: What to Consider When Treating Spasticity
Multiple sclerosis is a progressive, chronic neurodegenerative disease that impacts over 80,000 people in Canada, and more than 2.3 million people globally. In August 2010, nabiximols…